ADVM: Adverum Biotechnologies, Inc. Stock

by  •  • Comments Off on ADVM: Adverum Biotechnologies, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 228.30
Enterprise Value ($M) 153.30
Book Value ($M) 83.47
Book Value / Share 4.02
Price / Book 2.74
NCAV ($M) 13.23
NCAV / Share 0.64
Price / NCAV 17.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 4.13
Current Ratio 4.13

Balance Sheet (mrq) ($M)
Current Assets 102.77
Assets 173.01
Liabilities 89.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.60
Operating Income -123.77
Net Income -117.17
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -90.90
Cash from Investing 96.88
Cash from Financing 0.07

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-22 13G Logos Global Management LP 7.20
02-15 13G TCG Crossover GP II, LLC 9.90
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 7.50 163.82
02-14 13G/A Commodore Capital Lp 9.90 62.39
02-14 13G Vivo Opportunity Fund Holdings, L.P. 7.20
02-13 13G/A Bank Of America Corp /de/ 4.40 -20.85
02-12 13G/A Morgan Stanley 5.10 -27.81
02-09 13G/A Fmr Llc 6.06 -21.21
02-09 13G Frazier Life Sciences Public Fund, L.P. 5.00
02-07 13G/A BML Investment Partners, L.P. 2.30 -33.51

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K _______________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 42,340 285,990 14.80
2024-04-23 26,098 239,395 10.90
2024-04-22 22,837 155,235 14.71
2024-04-19 19,280 43,340 44.49

(click for more detail)

Similar Companies
ACXP – Acurx Pharmaceuticals, Inc. ADIL – Adial Pharmaceuticals, Inc.
ADTX – Aditxt, Inc. AEZS – Aeterna Zentaris Inc.
AFMD – Affimed N.V.


Financial data and stock pages provided by
Fintel.io